News
- UK University Hospitals build the NoRCoRP platform
- Scientists tackle vaccine safety, efficacy and access at global R&D forum
- Federal judge enters consent decree against Washington state juice processor
- FDA Warns Firms to Remove Unauthorized E-liquid Products from Market in First Letters Issued to Manufacturers that Did Not Submit Premarket Applications by Deadline
- Family physicians’ crucial role in mental health
- FDA Grants First Conditional Approval Under Expanded Authority to Control Seizures in Dogs with Idiopathic Epilepsy
- Universal health coverage high on the political agenda during the Regional Director’s visit to Georgia
- CBP, FDA Seize Counterfeit, Unauthorized E-Cigarettes
- EMA receives application for conditional marketing authorisation of COVID-19 Vaccine AstraZeneca
- FDA Releases Artificial Intelligence/Machine Learning Action Plan
- UNICEF, WHO, IFRC and MSF announce the establishment of a global Ebola vaccine stockpile
- WHO urges governments to promote healthy food in public facilities
- FDA Conditionally Approves First Oral Tablet to Treat Lymphoma in Dogs
- Neglected tropical diseases: WHO to formally launch new road map for next decade
- Canadian University initiated COVID-19 Emergency Department Registry
- Research Association conducts clinical trial of Eye Movements Recording Using a Smartphone
- Five million COVID-19 cases reported in WHO's Eastern Mediterranean Region
- FDA Issues Alert Regarding SARS-CoV-2 Viral Mutation to Health Care Providers and Clinical Laboratory Staff
- Large clinical trial will test combination monoclonal antibody therapy for mild/moderate COVID-19
- FDA Statement on Following the Authorized Dosing Schedules for COVID-19 Vaccines
- Extra dose from vials of Comirnaty COVID-19 vaccine
- EMA recommends COVID-19 Vaccine Moderna for authorisation in the EU
- FDA Takes Steps to Provide Clarity on Developing New Drug Products in the Age of Individualized Medicine
- HHS Announces $22 Billion in Funding to Support Expanded Testing, Vaccination Distribution
- US Institute conducts cclinical trial of Safety, Tolerability and Acceptability of Long-Acting Cabotegravir (CAB LA) for the Prevention of HIV Among Adolescent Males
Clinical Research News
다가오는 임상 시험
-
Aperta Biosciences, LLC아직 모집하지 않음
-
Hospices Civils de Lyon아직 모집하지 않음요실금 | 신경성 방광 | 요로 전환 | 골반 악성종양 | 방광암프랑스
-
Second Affiliated Hospital, Zhejiang University...모병정상적인 청력 | 소음 노출 | Preferred Loudness Level중국
-
Qilu Pharmaceutical Co., Ltd.아직 모집하지 않음투명 세포 신장 세포 암종 | 난소 암 | 기타 진행성 고형 종양중국
-
University Hospital, Antwerp아직 모집하지 않음신생아의 괴사성 소장결장염 | 후기 발병 신생아 패혈증벨기에, 네덜란드
-
VA Office of Research and Development아직 모집하지 않음전이성 비소세포폐암 | Cancer-Associated Weight Loss | Elevated Inflammatory Markers미국
-
ENTire Medical Ltd.아직 모집하지 않음비대 | 편도선 절제술 | 기도 폐쇄 갑피 | 아데노이드절제술미국
-
AbbVie아직 모집하지 않음
-
Institute of Hematology & Blood Diseases Hospital...모병
-
Ahmed Nasser Ali Mabkhout모병턱 낭종 | Alveolar Bone Defects예멘
-
University of Coimbra아직 모집하지 않음
